The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation

Asthma affects over 355 million people globally and poses a major healthcare burden. While corticosteroids remain a cornerstone of treatment, their side effects highlight the need for additional therapeutic strategies. Environmental exposures such as traditional farm dust have been linked to protect...

Full description

Saved in:
Bibliographic Details
Published in:Allergy (Copenhagen)
Main Authors: Korkmaz, Rabia Ülkü, Omony, Jimmy, Tan, Xiaomei, Klotz, Markus, Dragunas, Guilherme, Chen, Sirui, Shankhwar, Soni, Ertüz, Zeynep, Müller, Christoph, Ragab, Mohab, Jeridi, Aicha, Augustin, Romina, Nawroth, Janna, Kapellos, Theodore S., Rankl, Bettina, Yildirim, Ali Önder, von Mutius, Erika
Format: Journal Article
Language:English
Published: Denmark 22.10.2025
Subjects:
regulatory T cells
prophylactic intervention
asthma
epithelial barrier
Th2 inflammation
farm dust extract
ISSN:0105-4538, 1398-9995, 1398-9995
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Asthma affects over 355 million people globally and poses a major healthcare burden. While corticosteroids remain a cornerstone of treatment, their side effects highlight the need for additional therapeutic strategies. Environmental exposures such as traditional farm dust have been linked to protection against asthma and allergies. This study investigated the therapeutic potential of farm dust extract (FDE) in a murine model of allergic asthma when administered after sensitization and during allergen challenge, mimicking a secondary prevention or early interventional treatment approach. We used an ovalbumin (OVA)-induced asthma model to evaluate FDE effects on airway eosinophilia, airway hyperresponsiveness (AHR), mucus production, and IgE levels. Mechanistic studies assessed regulatory T cells (Tregs), dendritic cell phenotype, epithelial barrier integrity, and cytokine signaling. Complementary experiments were performed in peripheral blood mononuclear cells (PBMCs) from asthmatic donors. FDE significantly reduced airway inflammation and AHR, with secondary prevention effects comparable to systemic dexamethasone. FDE enhanced Treg frequency and CTLA-4 expression, modulated dendritic cell MHC-II and PD-L1 expression, and promoted an immunoregulatory environment. It also restored epithelial barrier integrity and increased IL-33 release, supporting Treg activation. In asthmatic PBMCs, FDE increased Tregs, reduced Th2 cells, and suppressed CIITA, suggesting similar immune-regulatory effects. Interactions among IL-33, amphiregulin (AREG), and Tregs highlighted a mechanism reinforcing immune-epithelial homeostasis. FDE administered after sensitization and during allergen challenge mitigated key asthma features in mice and showed translational potential in human cells, supporting its development as a novel, environmentally derived immunomodulatory strategy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0105-4538
1398-9995
1398-9995
DOI:10.1111/all.70121